MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 31.86% |
| Q2 2025 | -53.17% |
| Q1 2025 | -12.28% |
| Q4 2024 | -36.39% |
| Q3 2024 | 33.13% |
| Q2 2024 | 29.15% |
| Q1 2024 | 30.15% |
| Q4 2023 | -6.70% |
| Q3 2023 | 17.44% |
| Q2 2023 | -8.99% |
| Q1 2023 | 26.81% |
| Q4 2022 | -22.70% |
| Q3 2022 | -3.58% |
| Q2 2022 | 21.40% |
| Q1 2022 | -34.90% |
| Q4 2021 | 59.59% |
| Q3 2021 | -125.20% |
| Q2 2021 | -64.71% |
| Q1 2021 | -150.56% |
| Q4 2020 | 74.60% |
| Q3 2020 | -39.55% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |